| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,999,282 ) |
| | 2024 | 2024 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43EY035893 | Advanced 3D model of the Human Cornea for Keratoconus | 000 | 1 | NIH | 1/31/2024 | $297,153 |
| | 2024 | 2024 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43AI174490 | A Novel Mechanism of Action Natural Product for Treatment of Drug-Resistant Gonorrhea | 000 | 1 | NIH | 4/18/2024 | $291,697 |
| | 2024 | 2024 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44AT011486 | Controlled Release Eczema Bandage (CREB) | 000 | 2 | NIH | 9/20/2024 | $656,274 |
| | 2024 | 2024 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44HD102269 | A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds | 000 | 3 | NIH | 6/26/2024 | $836,497 |
| | 2024 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW STE 300 | HUNTSVILLE | AL | 35806-2905 | MADISON | USA | R43GM150352 | Harmony AI: State of the Art Natural Language Processing for Genetic Engineering | 000 | 1 | NIH | 11/15/2023 | $8,053 |
| | 2024 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW STE 300 | HUNTSVILLE | AL | 35806-2905 | MADISON | USA | R43GM151927 | Harmony AI: Natural Language Processing Enabling Advanced Biomanufacturing | 000 | 1 | NIH | 11/8/2023 | $5,329 |
| | 2024 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R41GM145196 | Real-Time Quantitation of Transport Across Vascular-Tissue Interfaces in Organ-On-Chip Models Using In Situ Mass Spectrometry | 000 | 1 | NIH | 6/6/2024 | -$75,719 |
| | 2024 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43EY034422 | An in vitro model for screening penetration of ocular drug products | 000 | 1 | NIH | 8/16/2024 | $0 |
| | 2024 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM146559 | PredictSEP: A Predictive Diagnostic Assay for Sepsis | 000 | 1 | NIH | 7/30/2024 | $0 |
| | 2024 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | U01FD006929 | Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products | 000 | 3 | FDA | 4/27/2024 | -$13,870 |
| | 2024 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43AT011486 | Microbiome-Balancing Wraps for Managing Eczema | 000 | 1 | NIH | 1/11/2024 | $0 |
| | 2024 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44DC017408 | Individualized Vestibular Rehabilitation for Elderly with Self-Management and Gaming Elements | 000 | 3 | NIH | 1/17/2024 | -$917 |
| | 2024 | 2020 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43FD006979 | A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics | 000 | 1 | FDA | 4/29/2024 | -$5,215 |
|
| Issue Date FY: 2023 ( Subtotal = $1,392,568 ) |
| | 2023 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44HD102269 | A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds | 000 | 2 | NIH | 5/24/2023 | $837,111 |
| | 2023 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM151927 | Harmony AI: Natural Language Processing Enabling Advanced Biomanufacturing | 000 | 1 | NIH | 8/30/2023 | $223,880 |
| | 2023 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM150352 | Harmony AI: State of the Art Natural Language Processing for Genetic Engineering | 000 | 1 | NIH | 9/22/2023 | $335,438 |
| | 2023 | 2023 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44HD102269 | A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds | 001 | 2 | NIH | 6/7/2023 | $20,321 |
| | 2023 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM146559 | PredictSEP: A Predictive Diagnostic Assay for Sepsis | 000 | 1 | NIH | 9/11/2023 | $0 |
| | 2023 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44AR072169 | Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions | 000 | 3 | NIH | 8/16/2023 | $0 |
| | 2023 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43TR003959 | A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy | 000 | 1 | NIH | 2/14/2023 | -$208 |
| | 2023 | 2020 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43FD006979 | A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics | 000 | 1 | FDA | 1/5/2023 | $0 |
| | 2023 | 2019 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43HL147791 | Microfluidic Assay for Screening Vascular Cardiotoxicity | 000 | 1 | NIH | 3/15/2023 | -$15,956 |
| | 2023 | 2019 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44FD005345 | A Multiscale Simulation Toolkit for Computational Pharmacology of Trans/Intradermally Administered Compounds in Healthy and Diseased Population | 000 | 2 | FDA | 2/1/2023 | -$8,018 |
|
| Issue Date FY: 2022 ( Subtotal = $1,829,629 ) |
| | 2022 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM146559 | PredictSEP: A Predictive Diagnostic Assay for Sepsis | 000 | 1 | NIH | 7/18/2022 | $342,689 |
| | 2022 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43EY034422 | An in vitro model for screening penetration of ocular drug products | 000 | 1 | NIH | 8/24/2022 | $300,000 |
| | 2022 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R41GM145196 | Real-Time Quantitation of Transport Across Vascular-Tissue Interfaces in Organ-On-Chip Models Using In Situ Mass Spectrometry | 000 | 1 | NIH | 3/17/2022 | $314,215 |
| | 2022 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44AR072169 | Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions | 000 | 3 | NIH | 9/2/2022 | $836,797 |
| | 2022 | 2022 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | U01FD006929 | Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products | 000 | 3 | FDA | 6/7/2022 | $39,849 |
| | 2022 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44DC017408 | Individualized Vestibular Rehabilitation for Elderly with Self-Management and Gaming Elements | 000 | 3 | NIH | 9/26/2022 | $0 |
| | 2022 | 2020 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43FD006979 | A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics | 000 | 1 | FDA | 9/26/2022 | $0 |
| | 2022 | 2020 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43HD102269 | A Synergystic In Vitro-In Silico Model of the Placental Barrier for Predicting Fetal Exposure and Toxicity of Xenobiotic Compounds | 000 | 1 | NIH | 8/22/2022 | -$645 |
| | 2022 | 2020 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43HD101181 | A mechanism-based computational toolkit to optimize age-specific pediatric pulmonary drug delivery | 000 | 1 | NIH | 6/10/2022 | -$603 |
| | 2022 | 2019 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43HL147791 | Microfluidic Assay for Screening Vascular Cardiotoxicity | 000 | 1 | NIH | 11/16/2021 | -$2,673 |
| | 2022 | 2019 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43ES029891 | Rodents Derived Synthetic Blood Brain Barrier Models for Chemical Toxicity Screening | 000 | 1 | NIH | 2/22/2022 | $0 |
| | 2022 | 2019 | CFD RESEARCH CORP | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43CA232844 | Development of Inhibitors of cANGPTL4 for Pancreatic Cancer Therapeutics | 000 | 1 | NIH | 1/28/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,367,708 ) (Continued on the next page) |
| | 2021 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43AT011486 | Microbiome-Balancing Wraps for Managing Eczema | 000 | 1 | NIH | 7/28/2021 | $253,024 |
| | 2021 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | U01FD006929 | Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products | 000 | 2 | FDA | 8/3/2021 | $179,978 |
| | 2021 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43TR003959 | A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy | 000 | 1 | NIH | 7/14/2021 | $253,606 |
| | 2021 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44AR072169 | Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions | 000 | 2 | NIH | 9/24/2021 | $893,953 |
| | 2021 | 2021 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44DC017408 | Individualized Vestibular Rehabilitation for Elderly with Self-Management and Gaming Elements | 001 | 3 | NIH | 8/2/2021 | $793,588 |
| | 2021 | 2020 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44DC017408 | Individualized Vestibular Rehabilitation for Elderly with Self-Management and Gaming Elements | 000 | 2 | NIH | 10/27/2020 | $0 |
| | 2021 | 2020 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43FD006979 | A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics | 000 | 1 | FDA | 3/9/2021 | $0 |
| | 2021 | 2020 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43FD006979 | A Multiscale Toolkit for Predicting Clinical Pharmacological Response of Antibody Therapeutics | 001 | 1 | FDA | 6/29/2021 | $0 |
| | 2021 | 2019 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R44FD005345 | A Multiscale Simulation Toolkit for Computational Pharmacology of Trans/Intradermally Administered Compounds in Healthy and Diseased Population | 000 | 2 | FDA | 3/9/2021 | $0 |
| | 2021 | 2019 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43ES030652 | Microfluidic nasal epithelial ALI model to evaluate inhalationtoxicity caused by engineered nanomaterials | 000 | 1 | NIH | 7/10/2021 | -$5,990 |
| | 2021 | 2019 | CFD RESEARCH CORPORATION | 6820 MOQUIN DR NW | HUNTSVILLE | AL | 35806-2900 | MADISON | USA | R43GM133232 | A multiscale computational tool to simulate the PK of orally-administered drugs in the human GI tract | 000 | 1 | NIH | 6/26/2021 | -$452 |
|
